These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29189120)

  • 1. Critical Role of IL-8 Targeting in Gliomas.
    Kosmopoulos M; Christofides A; Drekolias D; Zavras PD; Gargalionis AN; Piperi C
    Curr Med Chem; 2018; 25(17):1954-1967. PubMed ID: 29189120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of IL-8 gene expression in gliomas by microRNA miR-93.
    Fabbri E; Brognara E; Montagner G; Ghimenton C; Eccher A; Cantù C; Khalil S; Bezzerri V; Provezza L; Bianchi N; Finotti A; Borgatti M; Moretto G; Chilosi M; Cabrini G; Gambari R
    BMC Cancer; 2015 Oct; 15():661. PubMed ID: 26449498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiological mechanisms regulated by cytokines in gliomas.
    Christofides A; Kosmopoulos M; Piperi C
    Cytokine; 2015 Feb; 71(2):377-84. PubMed ID: 25458967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.
    Brat DJ; Bellail AC; Van Meir EG
    Neuro Oncol; 2005 Apr; 7(2):122-33. PubMed ID: 15831231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
    Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
    Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential roles of aquaporin 4 in malignant gliomas.
    Lan YL; Wang X; Lou JC; Ma XC; Zhang B
    Oncotarget; 2017 May; 8(19):32345-32355. PubMed ID: 28423683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.
    Singh MK; Chaudhuri S; Bhattacharya D; Kumar P; Datta A; Chaudhuri S
    Int Immunopharmacol; 2015 Feb; 24(2):198-207. PubMed ID: 25528475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
    Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
    Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NOD- like Receptors in Glioma Angiogenesis: Insights into future therapeutic interventions.
    Saxena S; Jha S
    Cytokine Growth Factor Rev; 2017 Apr; 34():15-26. PubMed ID: 28233643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
    Wang Q; Zhu Y; Yang P
    Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways.
    Nakabayashi H; Shimizu K
    Cancer Sci; 2011 Feb; 102(2):393-9. PubMed ID: 21166955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Neurotrophin Signaling in Gliomagenesis: A Focus on the p75 Neurotrophin Receptor (p75
    Alshehri MM; Robbins SM; Senger DL
    Vitam Horm; 2017; 104():367-404. PubMed ID: 28215302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine network, a newly discovered target in high grade gliomas.
    Domanska UM; Kruizinga RC; den Dunnen WF; Timmer-Bosscha H; de Vries EG; Walenkamp AM
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):154-63. PubMed ID: 20709564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways.
    Zhao LN; Wang P; Liu YH; Cai H; Ma J; Liu LB; Xi Z; Li ZQ; Liu XB; Xue YX
    Cell Signal; 2017 Jan; 30():142-153. PubMed ID: 27693218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
    Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
    Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glioma stem cells: enough to terminate gliomagenesis?
    Dong J; Huang Q
    Chin Med J (Engl); 2011 Sep; 124(17):2756-63. PubMed ID: 22040437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging microtubule targets in glioma therapy.
    Katsetos CD; Reginato MJ; Baas PW; D'Agostino L; Legido A; Tuszyn Ski JA; Dráberová E; Dráber P
    Semin Pediatr Neurol; 2015 Mar; 22(1):49-72. PubMed ID: 25976261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.